Jim Cramer spoke with Glenn Tullman, the CEO of Allscripts (MDRX) about what the recent Medicare bill will do to his company. Tullman explained that the new Medicare bill will penalize companies for not using electronic prescription systems like the ones that Allscripts sells. “You can’t ask for a better endorsement than the government actually pushing your product,” Tullman said. Tullman went on to explained that Allscript’s acquisition of Mysis Healthcare Systems is on track and shareholders will get a special $5 a share cash divided once its finalized. Cramer told viewers that the stock will drop once that dividend is paid and Tullman agreed. “If you believe in the long-term premise, then that dip is a buying opportunity,” he said. Cramer likes the story here and if the stock falls on the dividend payout he urged investors to buy it. Join the fastest growing community of small cap investors at Stockhideout.com